ESTIMATED
05/28/2024
05/28/2024
(AS OF MARCH 31)
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | $5.80 | $5.80 | $5.80 |
Q2 2024 | 1 | -$0.26 | -$0.26 | -$0.26 |
Q3 2024 | 0 | $5.64 | $5.64 | $5.64 |
IceCure Medical Ltd last posted its earnings results on Tuesday, May 28th, 2024. The company reported $-0.08 earnings per share for the quarter, missing analysts' consensus estimates of $-0.08 by $0. The company had revenue of 736,350 for the quarter and had revenue of 3.23 M for the year. IceCure Medical Ltd has generated $0 earnings per share over the last year ($-0.32 diluted earnings per share) and currently has a price-to-earnings ratio of -2.36. IceCure Medical Ltd has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/28/2024 | Q1 2024 | -$0.08 | -$0.08 | 0 | $736,350 | $736,350 | 04/03/2024 | Q4 2023 | -$0.07 | -$0.07 | 0 | $3.70 M | $1.32 M | 09/29/2023 | Q3 2023 | -$0.09 | $327,000 | 08/14/2023 | Q2 2023 | -$0.09 | -$0.09 | 0 | $937,000 | 03/29/2023 | Q1 2023 | -$0.09 | -$0.08 | 0.01 | $710,000 | 12/05/2022 | Q4 2022 | -$0.11 | -$0.11 | 0 | $939,000 | 09/30/2022 | Q3 2022 | -$0.11 | $634,000 | 09/22/2022 | Q2 2022 | -$0.13 | $765,000 | 03/31/2022 | Q1 2022 | -$0.12 | $747,000 | 04/01/2022 | Q4 2021 | -$0.10 | $1.38 M | 09/30/2021 | Q3 2021 | -$0.09 | $681,000 | 06/30/2021 | Q2 2021 | -$0.09 | $637,000 | 03/31/2021 | Q1 2021 | -$0.07 | $1.44 M |
---|
A. IceCure Medical Ltd has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates.
A. The conference call for IceCure Medical Ltd's latest earnings report can be listened to online.
A. The conference call transcript for IceCure Medical Ltd's latest earnings report can be read online.
A. IceCure Medical Ltd (NASDAQ:ICCM) has a recorded annual revenue of $3.23 M.
A. IceCure Medical Ltd (NASDAQ:ICCM) has a recorded net income of $3.23 M. IceCure Medical Ltd has generated $-0.32 earnings per share over the last four quarters.
A. IceCure Medical Ltd (NASDAQ:ICCM) has a price-to-earnings ratio of -2.36 and price/earnings-to-growth ratio is -0.12.